article thumbnail

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease

Cardiovascular Diabetology

Objective To explore trends in prognosis and use of glucose-lowering drugs (GLD) in patients with diabetes and coronary artery disease (CAD). Research design and methods All patients with diabetes and CAD undergoing a coronary angiography between 2010 and 2021 according to the Swedish Angiography and Angioplasty Registry were included.

article thumbnail

Atherothrombotic Outcomes After Sodium‐Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase‐4 Inhibitors in Patients With Type 2 Diabetes: A Territory‐Wide Retrospective Cohort Study

Journal of the American Heart Association

ConclusionsSGLT2 inhibitors in patients with diabetes were independently associated with reduction in atherothrombotic major adverse cardiovascular events, allcause mortality, cardiovascular mortality, myocardial infarction, stroke, and incident dialysis, compared with DPP4 inhibitors.

article thumbnail

Hypoglycemic Events May Trigger Acute Ischemic Stroke Within 30 Days in Those With Diabetes: A Case-Crossover Study

Stroke Journal

We used conditional logistical regression models to estimate odds ratios and 95% CIs.RESULTS:There were 237 667 index admissions with AIS and diabetes during the study period. These results, if confirmed in other studies, emphasize the importance of avoiding hypoglycemic events in patients with diabetes.

article thumbnail

AFib Might Be Far More Common Than We Think

CardiacWire

UCSF researchers analyzed medical records from 29M adults who received hospital-based care in California from 2005 to 2019 (51yr avg. AFib rates increased dramatically during the study period, from 4.49% in 2005-2009 to 6.82% in 2015-2019. When these results are applied across the U.S., adult population.

AFIB 105
article thumbnail

Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study

Open Heart

Aims The aim of this study was to investigate a real-world heart failure (HF) cohort regarding (1) prevalence of known diabetes mellitus (DM), undiagnosed DM and pre-diabetes, (2) if hf treatment differs depending on glycaemic status and (3) if treatment of DM differs depending on HF phenotype.

article thumbnail

Heart disease in pregnancy and risk of pre-eclampsia: a Swedish register-based study

Open Heart

Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Hypertension and diabetes were independent risk factors for pre-eclampsia. It is not known whether heart failure increases the risk of pre-eclampsia.

article thumbnail

Abstract 262: National Trends of 90?day Readmission Rates and Etiologies among Diabetics following Transient Ischemic Attack

Stroke: Vascular and Interventional Neurology

Type 2 Diabetes Mellitus (T2DM) is a rapidly growing global health problem with increasing prevalence. from 2016‐2019 and secondary diagnosis of T2DM. from 2016‐2019 and secondary diagnosis of T2DM. Of those patients, 35.43% (n=273,993) were diabetic and 64.57% (n=151,112) were non‐diabetic.